Related references
Note: Only part of the references are listed.Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study
Laura M. Fernandez et al.
LANCET ONCOLOGY (2021)
A Clinically Applicable Gene-Expression Classifier Reveals Intrinsic and Extrinsic Contributions to Consensus Molecular Subtypes in Primary and Metastatic Colon Cancer
Robert Piskol et al.
CLINICAL CANCER RESEARCH (2019)
Locally advanced rectal cancer transcriptomic-based secretome analysis reveals novel biomarkers useful to identify patients according to neoadjuvant chemoradiotherapy response
Luisa Matos do Canto et al.
SCIENTIFIC REPORTS (2019)
Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study
Maxime J. M. van der Valk et al.
LANCET (2018)
A single institution's long-term follow-up of patients with pathological complete response in locally advanced rectal adenocarcinoma following neoadjuvant chemoradiotherapy
Franscois Runau et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2017)
Gene and MicroRNA Expression Are Predictive of Tumor Response in Rectal Adenocarcinoma Patients Treated With Preoperative Chemoradiotherapy
Caterina Millino et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer
Emmanouil Fokas et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin Signaling
Georg Emons et al.
MOLECULAR CANCER RESEARCH (2017)
Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer
Emmanouil Fokas et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Clinical utility of pretreatment prediction of chemoradiotherapy response in rectal cancer: a review
Byong Chul Yoo et al.
EPMA JOURNAL (2017)
Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: First results of the German CAO/ARO/AIO-04 randomized phase III trial.
C. Roedel et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis
Fahima Dossa et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
To Drain or Not to Drain Infraperitoneal Anastomosis After Rectal Excision for Cancer The GRECCAR 5 Randomized Trial
Quentin Denost et al.
ANNALS OF SURGERY (2017)
Current use of diverting stoma in anterior resection for cancer: population-based cohort study of total and partial mesorectal excision
Martin Rutegard et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2016)
Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review
J. E. Ryan et al.
COLORECTAL DISEASE (2016)
Male sexual dysfunction after rectal cancer surgery: Results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212
S. Saito et al.
EJSO (2016)
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
F. Cardoso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
LIG4 mediates Wnt signalling-induced radioresistance
Sohee Jun et al.
NATURE COMMUNICATIONS (2016)
Neoadjuvant Therapy in Rectal Cancer - Biobanking of Preoperative Tumor Biopsies
Peter Jo et al.
SCIENTIFIC REPORTS (2016)
An 80-gene set to predict response to preoperative chemoradiotherapy for rectal cancer by principle component analysis
Shinichiro Empuku et al.
MOLECULAR AND CLINICAL ONCOLOGY (2016)
Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment
Monique Maas et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Genomic Classifier ColoPrint Predicts Recurrence in Stage II Colorectal Cancer Patients More Accurately Than Clinical Factors
Scott Kopetz et al.
ONCOLOGIST (2015)
Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer
Camila Lopes-Ramos et al.
CANCER GENETICS (2015)
Predictive Biomarkers to Chemoradiation in Locally Advanced Rectal Cancer
Raquel Conde-Muino et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Tumor Regression Grading After Preoperative Chemoradiotherapy for Locally Advanced Rectal Carcinoma Revisited: Updated Results of the CAO/ARO/AIO-94 Trial
Emmanouil Fokas et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Complete Pathologic Response after Combined Modality Treatment for Rectal Cancer and Long-Term Survival: A Meta-Analysis
Luigi Zorcolo et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Why Your New Cancer Biomarker May Never Work: Recurrent Patterns and Remarkable Diversity in Biomarker Failures
Scott E. Kern
CANCER RESEARCH (2012)
The Rectal Cancer microRNAome - microRNA Expression in Rectal Cancer and Matched Normal Mucosa
Jochen Gaedcke et al.
CLINICAL CANCER RESEARCH (2012)
Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years
Rolf Sauer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial
Claus Roedel et al.
LANCET ONCOLOGY (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
P53 Status as a Predictive Biomarker for Patients Receiving Neoadjuvant Radiation-Based Treatment: A Meta-Analysis in Rectal Cancer
Min-Bin Chen et al.
PLOS ONE (2012)
Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy
Emil Kendziorra et al.
CARCINOGENESIS (2011)
Pretreatment Transcriptional Profiling for Predicting Response to Neoadjuvant Chemoradiotherapy in Rectal Adenocarcinoma
Kate H. Brettingham-Moore et al.
CLINICAL CANCER RESEARCH (2011)
Long-term Follow-up Features on Rectal MRI During a Wait-and-See Approach After a Clinical Complete Response in Patients With Rectal Cancer Treated With Chemoradiotherapy
Doenja M. J. Lambregts et al.
DISEASES OF THE COLON & RECTUM (2011)
A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets
Marian Grade et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Male sexual dysfunction after rectal cancer surgery
Yuji Nishizawa et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2011)
Validation Study of a Quantitative Multigene Reverse Transcriptase-Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer
Richard G. Gray et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Rectal cancer surgery: A brief history
Avi S. Galler et al.
SURGICAL ONCOLOGY-OXFORD (2011)
Pathologic Complete Response of Primary Tumor Following Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer Long-term Outcomes and Prognostic Significance of Pathologic Nodal Status (KROG 09-01)
Seung-Gu Yeo et al.
ANNALS OF SURGERY (2010)
Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX® Colon Cancer Assay
Kim M. Clark-Langone et al.
BMC CANCER (2010)
Anastomotic leakage after anterior resection for rectal cancer: risk factors
C. A. Bertelsen et al.
COLORECTAL DISEASE (2010)
A new sensitivity-preferred strategy to build prediction rules for therapy response of cancer patients using gene expression data
Klaus Jung et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2010)
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data
Monique Maas et al.
LANCET ONCOLOGY (2010)
Urinary dysfunction after rectal cancer treatment is mainly caused by surgery
M. M. Lange et al.
BRITISH JOURNAL OF SURGERY (2008)
Chemoradiotherapy for rectal cancer: An updated analysis of factors affecting pathological response
P. Sanghera et al.
CLINICAL ONCOLOGY (2008)
Risk factors for faecal incontinence after rectal cancer treatment
M. M. Lange et al.
BRITISH JOURNAL OF SURGERY (2007)
Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer
Il-Jin Kim et al.
DISEASES OF THE COLON & RECTUM (2007)
Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles
T Watanabe et al.
CANCER RESEARCH (2006)
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer
C Rödel et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy
BM Ghadimi et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy - Long-term results
A Habr-Gama et al.
ANNALS OF SURGERY (2004)
Preoperative versus postoperative chemoradiotherapy for rectal cancer
R Sauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
